Close Menu

TechCrunch wonders where Sergey Brin went. As you may recall, Brin's blog, called too, made a splash when it appeared in September. The second entry on the blog (right after the introductory post) announced that Brin has the LRRK2 gene for familial Parkinson's disease. As TechCrunch's Robin Wauters points out, there was never a third post.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.